Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: Final results from CALGB trial 79809

Saved in:
Bibliographic Details
Title: Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: Final results from CALGB trial 79809
Authors: Shapiro, C.L.1 charles.shapiro@osumc.edu, Halabi, S.2, Hars, V.2, Archer, L.2, Weckstein, D.3, Kirshner, J.4, Sikov, W.5, Winer, E.6, Burstein, H.J.6, Hudis, C.7, Isaacs, C.8, Schilsky, R.9, Paskett, E.1
Source: European Journal of Cancer. Mar2011, Vol. 47 Issue 5, p683-689. 7p.
Database: Academic Search Ultimate
Description
ISSN:09598049
DOI:10.1016/j.ejca.2010.11.024